Biohit's Financial Reporting and Annual General Meeting in 2016
Biohit Oyj Stock Exchange Release, December 4, 2015 at 9:30 A.M. local time (EET)
Biohit will release its financial statements for 2015 on Thursday 25th of February 2016 at 9:30 AM.
Biohit Oyj’s Annual General Meeting has been planned for Monday 25th of April 2016 at 3:00 PM local time in Helsinki, Finland. The Board of Directors will call the General Meeting at a later date.
Company will publish three interim reports in 2016, based on the following schedule:
• Interim report for period January - March 2016 (Q1) on Thursday 12th of May 2016 at 9:30 AM.
• Interim report for period January - June 2016 (Q2) on Thursday 18th of August 2016 at 9:30 AM.
• Interim report for period January - September 2016 (Q3) on Thursday 20th of October 2016 at 9:30 AM.
The published economic reports and other stock exchange releases will be available on Biohit's website at www.biohithealthcare.com/investors. The website also contains an online form for ordering electronic copies, which will be e-mailed to you, available at http://www.biohithealthcare.com/investors/stock-exchange-releases/order-releases-to-your-email.
Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com
|